References
- WaniMCTaylorHLWallMECoggonPMcPhailATPlant antitumor agents. VI. The isolation and structure of taxol, a novel anti-leukemic and antitumor agent from Taxus brevifoliaJ Am Chem Soc197193232523275553076
- WeissRDonehowerRCWiernikPHHypersensitivity reactions from TaxolJ Clin Oncol19908126312681972736
- Meerum TerwogtJMNuijenBHuininkTenBokkelWWBeijnenJHAlternative formulations of paclitaxelCancer Treat Rev19972387959225960
- HamaguchiTMatsumuraYSuzikiMNK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBr J Cancer2005921240124615785749
- KatoKHamaguchiTYasuiHPhase I study of NK105, a paclitaxel-incorporating micellar nanoparticle, in patients with advanced cancerJ Clin Oncol20062418S2018
- ChinKKatoKYoshikawaTPhase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancerJ Clin Oncol20102815S4041
- KimSCKimDWShimYHIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacyJ Control Release20017219120211389998
- KimTYKimDWChungJYPhase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignanciesClin Cancer Res2004103708371615173077
- LeeKSChungHCImSAMulticenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerBreast Cancer Res Treat200810824125017476588
- Di LeoAGomezHLAzizZPhase II, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancerJ Clin Oncol2008265544555218955454
- JonesSEErbanJOvermoyerBRandomized phase III study of decetaxel compared with paclitaxel in metastatic breast cancerJ Clin Oncol2005235542555116110015
- ParidaensRBiganzoliLBruningPPaclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-overJ Clin Oncol20001872473310673513
- DuncanRThe dawning era of polymer therapeuticsNat Rev Drug Discov2003234736012750738
- HaagRKratzFPolymer therapeutics: concepts and applicationsAngew Chem Int Ed20064511981215
- O’BrienMERSocinskiMAPopovichAYRandomized phase III trial comparing sing-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancerJ Thoracic Oncol20083728734
- Paz-AresLRossHO’BrienMPhase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancerBr J Cancer2008981608161318475293
- US National Institute of HealthClincalTrails.gov Available from: http://clinicaltrials.gov/Accessed 2010 Dec 02
- VanSDasSKWangXSynthesis, characterization, and biological evaluation of poly(L-γ-glutamylglutamine)-paclitaxel nanoconjugateInt J Nanomedicine2010582583721042550
- FengZZhaoGYuLGoughDHowellSBPreclinical efficacy studies of a novel nano-particle-based formulation of paclitaxel that out-performs AbraxaneCancer Chemother Pharmacol20106592393019685054
- WangXZhaoGVanSPharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsCancer Chemother Pharmacol20106551552619593566
- MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumor agent smancCancer Res198646638763922946403
- MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000291723
- HealdCRStolnikSKujawinskiKSPoly(lactic acid)–poly(ethylene oxide) (PLA−PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG coronaLangmuir20021836693675
- HrkachJSPeracchiaMTDombALotanNLangerRNanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopyBiomaterials19971827309003893